Nature biotechnology

Chemical and structural design of multi-capped mRNA and capped circular RNA to improve protein production

Updated

Abstract

mRNA protein production was enhanced by up to tenfold in vivo using a new method called ligation-enabled mRNA-oligonucleotide assembly (LEGO).

  • A branched mRNA cap effectively initiates translation on both linear and circular mRNAs without the need for internal ribosome entry sites.
  • Chemical modifications, including locked nucleic acid (LNA) N-methylguanosine on the cap and additional LNA modifications on the 5' untranslated region, improve the binding of translation initiation factors and RNA stability.
  • In a vaccine setting for severe acute respiratory syndrome coronavirus 2, this method resulted in 17-fold and 3.7-fold increases in antibody production after prime and boost doses, respectively.
  • The LEGO platform allows for the design of non-traditional RNA structures and topologies that could be useful in both research and therapeutic contexts.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interests: X.W., H.C., D.L., A.A. and J.G. are inventors of patent applications related to this work. X.W. is a consultant, equity holder and scientific cofounder of Stellaromics and Convergence Bio. R.J.X. is a cofounder of Celsius Therapeutics and Jnana Therapeutics, scientific advisory board member at Nestle and board director at MoonLake Immunotherapeutics. F.Z. is a scientific advisor and cofounder of Editas Medicine, Beam Therapeutics, Pairwise Plants, Arbor Biotechnologies, Proof Diagnostics, Aera Therapeutics and Moonwalk Biosciences. F.Z. is a scientific advisor for Octant. The remaining authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free